Clinical Trial Update: Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating blockade of the renin-angiotensin-aldosterone system in Arrhythmogenic Right Ventricular Dysplasia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Right Ventricular Dysplasia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Arrhythmogenic Right Ventricular Dysplasia | Phase 2 | Status: RECRUITING